ProBiotix Health signs partner agreement with SymbioPharm

ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops probiotic formulations to support cardiometabolic health, has entered into a new partnership agreement with SymbioPharm that enables the dietary supplement brand to utilise the CholBiome®CH formulation from ProBiotix to target and reduce cholesterol in its branded range of consumer products. SymbioPharm, the pioneering German company specialising […]

ProBiotix Health launches new dual-action cholesterol reducing bi-layer tablet CholBiome®CH at Vitafoods Europe

ProBiotix Health plc (‘ProBiotix’), a global market leader in microbiome modulation technology in the life sciences industry, has added to its growing range of science-backed cholesterol-reducing products with CholBiome®CH. The latest innovation from ProBiotix, which will launch at Vitafoods Europe this year, is a result of new regulations from the European Food Safety Authority (EFSA) […]